chrisvoncsefalvay/vaers-outcomes huggingface dataset:
2 weeks after 2nd dose, around March 1st,  blood pressure  was extremely high and uncontrollably.  I went to get a prescreening for a colonoscopy and that's when the doctor notified me that my blood pressure was extremely high and advised me to see my PCP. The PCP put me on Lisinopril, Amlodipine, Metoprolol.   On May 10th, I had an exercise stress test and the cardiologist stopped the test. He saw 2 abnormalities on the EKG after 4 1/2 minutes.  He referred me the the cardiac unit  at the hospital  on May 25, 2021, to do a heart catherization , and they placed 4 stints in the artery to my heart.It was in the widow maker artery. After the surgery I have been prescribed the Plavix-blood thinner, and baby aspirin .Prior to taking the Pfizer dose 1, I never had high blood pressure or had to take blood pressure medication or blood thinners.
on the morning on 1/7 pt had tinnitus in his R ear and then complete hearing loss confirmed by audiologist.  Seen by ENT and placed on oral steroid course with return to baseline hearing within a week
small spot on their hands that peeling,both hands are; rash starting to itch; fingernails are beginning to crack; rash all over,backside of both arms,rash on their back,backside of both thighs; backside of both thighs along with the rash thighs are red; backside of both thighs along with the rash thighs are sore; This spontaneous case was reported by a consumer and describes the occurrence of SKIN EXFOLIATION (small spot on their hands that peeling,both hands are), RASH PRURITIC (rash starting to itch), ONYCHOCLASIS (fingernails are beginning to crack), RASH (rash all over,backside of both arms,rash on their back,backside of both thighs) and ERYTHEMA (backside of both thighs along with the rash thighs are red) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SKIN EXFOLIATION (small spot on their hands that peeling,both hands are), RASH PRURITIC (rash starting to itch), ONYCHOCLASIS (fingernails are beginning to crack), RASH (rash all over,backside of both arms,rash on their back,backside of both thighs), ERYTHEMA (backside of both thighs along with the rash thighs are red) and MYALGIA (backside of both thighs along with the rash thighs are sore). At the time of the report, SKIN EXFOLIATION (small spot on their hands that peeling,both hands are), RASH PRURITIC (rash starting to itch), ONYCHOCLASIS (fingernails are beginning to crack), RASH (rash all over,backside of both arms,rash on their back,backside of both thighs), ERYTHEMA (backside of both thighs along with the rash thighs are red) and MYALGIA (backside of both thighs along with the rash thighs are sore) outcome was unknown.            No Concomitants included. No Treatment was reported by the reporter.
Patient got Pfizer dose as 2nd dose ... should have been Moderna. Patient did not have cdc card for the 1st vaccine, then once she was vaccinated, she came back and had determined she got Moderna as the first dose.
My arm is itchy (started after the 2nd dose a week later).; For my 2nd dose I had every single side effect listed; Constipation; For my period this was amazing. First time every I had zero cramps; Instead of cramps I got headache which normally doesn't happen for me; my period was affected.; bloating; diarrhea; Nausea; This is a spontaneous report from a non-contactable consumer (patient) via company representative. A 42-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number and Expiration date: unknown), 2nd dose via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. Medical history included eczema, other period symptoms bloating, diarrhea and nausea, birth control and cramps (when the patient was on birth control). The patient's concomitant medications were not reported. The patient previously received first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date, as single dose for COVID-19 immunization. On an unspecified date, the patient experienced "My arm is itchy (started after the 2nd dose a week later)" and "my period was affected". She mentioned that "for my 2nd dose I had every single side effect listed", even constipation (which was not on the list). Her arm was still itchy and she was definitely worried. She don't need that on her arm since she already deals with eczema. She further stated that "for my period this vaccine was amazing, first time every I had zero cramps" and that happened only when she was on birth control in the past. All her other period symptoms were there which included bloating, diarrhea and nausea. "Instead of cramps I got headache which normally doesn't happen for me". She did not report this to her health care professional. The outcome of the event pruritus was not resolved and was unknown for rest all other events.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
a 5 years old patient was given a dose of Flublok quadrivalent influenza vaccine/No AE; Initial information received on 10-Oct-2019 regarding an unsolicited valid non-serious case received from a consumer (office staff).  This case is linked to case 2019SA284455 (same reporter).  This case involves a five years old female patient who was given a 0.5 ml dose of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] lot QFAA1929, expiry date: 30-Jun-2020 via intramuscular route in the right thigh on 08-Oct-2019  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was an actual medication error due to inappropriate age at vaccine administration.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Pt developed dizziness, face pain, and scratchy throat immediately after vaccine. Pt had slight elevated blood pressure (160/100 which came down to 139/102 over the next 3-4 readings over 30-45 min). Pt remained in IMZ room with ice pack and legs elevated for ~ one hour. Pt's symptoms did not progress any further and the throat issue seemed to go away according to Pt so she went home with her sister.
administered Flublok to a 5 year-old child, rather than the intended Fluzone/ no AE; administered Flublok to a 5 year-old child, rather than the intended Fluzone/ no AE; Initial information received on 01-Nov-2019 regarding an unsolicited valid non-serious case received from a physician.  This case involves a 5 years old patient who received 0.5 ml INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV] lot QFAA1963 (Expiry date 30-Jun-2020)  via intramuscular route in the left deltoid on 01-Nov-2019 instead of intended INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QUADRIVALENT].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   It was an actual medication error case due to inappropriate age at vaccine administration and wrong vaccine administered. It was reported that physician administered Flublok to a 5 year-old child, rather than the intended Fluzone.  At the time of reporting no adverse reaction was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sudden onset chest pain diagnosed as an acute inferior STEMI treated with thrombolytic therapy.  Cath with an occluded mid right posterolateral branch from thrombus.  Still recovering less than 24 hours after the event.
Red rash formed on day 8 4/28 rash is now bigger warm and itchy
Swelling, red rash. Pt reported symptoms to me today, 9/18/13, stating that the site was not painful or hot, just red and itchy, and that the symptoms had improved since the reaction started on 9/13/13.
CHIEF COMPLAINT / REASON FOR CALL COVID Inquiry/OB ICP enrollment Day 0=10/13/21   Information Discussed Patient was called to follow up on her COVID+ diagnosis from 10/13/2021. She reported receiving a positive COVID test result from her screening test for her upcoming  c-section scheduled for 10/15/2021. She denied any symptoms at all. No other family members are sick. All other family members are vaccinated except her 2 year old son.  Reviewed with patient what to do if she experienced worsening of symptoms or emergent symptoms. Contact number for OB Triage provided. Discussed OB ICP COVID monitoring with patient. She agreed to participation in the program and she was enrolled. A portal message was sent to patient with parameters for normal limits of vital signs. Patient's address was verified and it was explained that a COVID vital signs monitoring equipment kit would be mailed to her address.
Student reported to Campus health services on Friday, February 26th after receiving the COVID vaccination on the prior Wednesday. Student reported development of symptoms the Thursday after vaccination.   Student presented with redness, firmness, induration, pain and warmth to injection site. Induration measured at 47mm diameter.   Student reported back Monday, March 1st. Redness resolved. Still firmness at approx 50 mm in diameter. So pain, but improvement.
Patient was administered expired vaccine- realized after administration.  We contacted and are awaiting Moderna support to call/email to advise of necessary next steps (ie if another vaccine is needed). Patient has not reported any issue.
Information has been received from a registered nurse referring to a 36 day old patient of unknown gender. The patient's pertinent medical history, drug reactions/allergies, current condition and concomitant medication were not provided. On 29-NOV-2018 the patient was administered the first dose of ROTATEQ (lot # R007992 with expiration date 19-OCT-2019) orally for prophylaxis (inappropriate age at vaccine administration). No adverse effects were reported.
WHOLE FACE FEELS ITCHY; ITCHY EYES; ITCHY NOSE; VERY RUNNY NOSE; WATERING EYES; This spontaneous report received from a patient concerned a 58 year old female. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802070 expiry: UNKNOWN) dose was not reported, around 8 to 10 am administered to left arm on 30-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 01-APR-2021, the subject experienced itchy eyes. On 01-APR-2021, the subject experienced nasal itching. On 01-APR-2021, the subject experienced very runny nose. On 01-APR-2021, the subject experienced watering eyes. On 05-APR-2021, the subject experienced whole face feels itchy. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from itchy eyes, nasal itching, very runny nose, watering eyes, and whole face feels itchy. This report was non-serious.
wasn't making sense in conversation, starred off/Could not talk; Very groggy; could not  respond, couldn't follow instructions or directions; not his normal self; shaking; Patient not his normal self; Starred off when spoke to; A spontaneous report  was received from a consumer for a 79 year old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced tremor (shaking), speech disorder (wasn't making sense in conversation, starred off/could not talk), somnolence (very groggy), vaccination related malaise (not his normal self), and cognitive disorder (could not respond, couldn't follow instructions or directions).  The patient's medical history was not provided. No concomitant product use was reported.  On an 07 Mar 2021, the patient received the first of two planned doses of mRNA-1273 (Lot number: 029A21A) intramuscularly for prophylaxis of COVID-19 infection.    On 08 Mar 2021, The patient experienced tremor (shaking), speech disorder (wasn't making sense in conversation, starred off/could not talk, feeling abnormal (not his normal self), vaccination related malaise(not his normal self), and cognitive disorder (could not respond, couldn't follow instructions or directions).  On 08-Mar-2021, the patient was admitted to the hospital. On the day of hospital admission, the patient experienced somnolence (very groggy) and was known to have elevated cardiac enzymes.  Treatment information was unknown.  Action taken with mRNA-1273 was unknown.  The outcome of the events, tremor (shaking), speech disorder (wasn't making sense in conversation, starred off/could not talk), somnolence (very groggy), vaccination related malaise (not his normal self), and cognitive disorder (could not respond, couldn't follow instructions or directions), were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Hypotension-Medium
My arm was really sore for a couple days and that was it. I tested positive with a home test for COVID-19 on 08/31/2022. I had no symptoms prior, but I work up with a fever, chills, achy, headache, sore throat. I called my doctor and was prescribed PAXLOVID. I had no trouble taking the PALOVID. Twelve days later, I tested negative for COVID-19. As of today, I continue to have fatigue and brain fog but I'm getting better each day.
Nausea, Chills, Vertigo, Mild Diaphoresis.  Re-hydrated with oral fluids @ patient's own pace.  Improvement reported with interview ~12:30 pm.
Tinnitus.  Constant.  Bilateral.  It's been persistent since onset through the present.
Patient received Pfizer for first dose and 3 weeks later received Moderna vaccine for second dose
fatigued and tired; weak; This is a spontaneous report from a contactable consumer (patient's wife). A 63-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL8982), via an unspecified route of administration (arm) on 19Jan2021 at single dose for Covid-19 immunization (also reported as Covid protection). The patient has no medical history. The patient's concomitant medications were not reported. The reporter confirmed that the patient does take other medications, but they never make him tired or weak. The reporter also confirmed that the patient did not receive any other vaccines on the same day as the COVID vaccine. It was reported that the patient took the Covid 19 vaccine on Tuesday (19Jan2021). The patient was fatigued and tired on 21Jan2021. It was further reported that the patient was tired and weak on 21Jan2021. The reporter added that that she knows tiredness and weakness are known side effects of the product, but she wanted to know how long after they get the vaccine those side effects last, and to what degree do they occur. The outcome of events was unknown.
This spontaneous report as received from a nurse refers to 9 unspecified patients of unknown age and gender. Relevant medical history and concomitant medication were not provided. On an unknown date the patients were vaccinated with RECOMBIVAX HB lot # J001183. Dose, route and frequency were not provided. On an unknown date the patients received doses of RECOMBIVAX HB from recalled lot number. No adverse event was reported. The reporter considered patients received doses of RECOMBIVAX HB from recalled lot number to be not related to RECOMBIVAX HB. Additional information has been requested.
When I was Vaccinated on March 15, 2021 with the Pfizer vaccine I noticed a high pitch sound in my ears about three days later.  I was vaccinated with my second dose on 4/7/2021 and the tinnitus got worse, I continued to hear the frequency type sound for about three months it began to subside.  I had my booster in October, and with in a day began to hear the tinnitus in my left ear again. It has not stopped.  I am a pfizer share holder, I and my entire family are fully vaccinated. I am the only one that experienced this.  I assumed it was vaccine related but could not confirm it until it returned directly after my booster. I assume it will subside as it did the first time.
Rash 5 min p/vax on lt deltoid/arm; rash/hives spread to thorax/abdomen w/in 10 min p/vax; pt saw MD who examined pt & prescribed oral Benadryl 50 mg q/6-8 hr PRN;
This is a prospective pregnancy case. This 31-year-old female subject was enrolled in a study during pregnancy or within 28 days preceding conception. On 15th October 2014, the subject received Flu QIV .5 ml. On an unknown date, an unknown time after receiving Flu QIV the subject developed exposure during pregnancy (Non-serious). The outcome of exposure during pregnancy was unknown. The pregnancy was ongoing. It was unknown if the investigator considered the exposure during pregnancy to be related to Flu QIV.
In addition to commonly reported side effects (headache, mild muscle pain and stiffness), approximately 18 hours post-injection  distinctive systems normally associated with escitalopram withdrawal, mainly electric shock sensations in face and 'brain zaps,' began occurring.  Symptoms disappeared within approximately an hour of taking normal daily dose of escitalopram (20 mg). Approximately 10 hours later, symptoms reappeared with similar severity, and a half-dose of of escitalopram was taken (10 mg). Again, within about an hour symptoms disappeared. No further symptoms have occurred as of >48 hours post-injection. No additional effects observed, and overall recovery from other post-vaccine symptoms proceeded quickly.
Patient Recieved VacciNe from An vial.that shouldve been "wasted" on 8/5/2021. No furtheR sxs since Recieving the vacciNe on 8/10/2021
Feverish, chills, nausea. Started the day aftet gettinng the shot and still persist at night the next day.
1 hour after anthrax vaccine #2 the patient developed a week of headaches and myalgia.
I had a seizure 4 weeks after my first shot and 3 seizures 2 weeks after my second shot. All my tests came back negative and there is nothing obvious causing the seizures, i.e. brain tumor, ekg, ct scan, etc. I have also been suffering from headaches since my second shot. I have never before suffered from headaches or I have never experienced a seizure before these two episodes.
Chills & fever for one day. Large (5-inch) diameter red swollen area where injected. Fever in arm. Joint pain.
Gastro symptoms; Gastric pain; Pain in the arm; Nausea; Headache; Muscle aches; Fever; This spontaneous case was reported by a consumer and describes the occurrence of GASTROINTESTINAL DISORDER, ABDOMINAL PAIN UPPER, PAIN IN EXTREMITY, NAUSEA, and HEADACHE in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A and 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included ATACAND for an unknown indication.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced GASTROINTESTINAL DISORDER (Gastro symptoms), ABDOMINAL PAIN UPPER, PAIN IN EXTREMITY, NAUSEA, HEADACHE, MYALGIA, and PYREXIA. At the time of the report, GASTROINTESTINAL DISORDER, ABDOMINAL PAIN UPPER, PAIN IN EXTREMITY, NAUSEA, HEADACHE, MYALGIA, and PYREXIA outcome was unknown.            Treatment information was not provided.   This case was linked to MOD-2021-370262, MOD-2021-370458 (Patient Link).
Delayed menstrual cycle, over 10 days late which is unusual.  Other symptoms were moderate flu like symptoms for a day and a half after the vaccine. This included headache, muscle aches, fever, chills and fatigue.
I was positive for COVID-19 on 04FEB2023, I had a sore throat, I had fever and body aches and general flu like symptoms. I contacted my doctor and prescribed me PAXLOVID, I started feeling better about 48 hours after taking the medication.
Pain along left collarbone. Pain increases when attempting to lift left arm. Light swelling. Some numbness between left shoulder and left elbow. Pain began subsiding after approx. 48 hours, and declined gradually over next 48 hours, until no symptoms remained.
39 years old female patient receive Pfizer bivalent booster lot # GH9694 on 9/17/22. Patient started feeling dizzy at 1415. Patient has been transferred to the gurney. Patient stated of having itchiness and scratchy feeling on her throat area. Benadryl IM 50mg/1ml was administered on patient's RD. Patient's VS were as the following: At 1415 BP 158/95 HR 88 O2. At 1420 BP 158/90 HR 88 O2 98%. 1435 BP 178/97 HR 86 O2 98%. At 1440 Patient was stable and stated of feeling better. Patient was educated regarding side effects of Benadryl and instructed to seek medical services for any unusual feeling. Patient was transferred with a wheelchair to the car. Patient left the clinic with her husband.
Medical Assistant calling to report a limited adverse event on a dose of PROQUAD; PROQUAD that was administered improperly stored during a temperature excursion; This spontaneous report was received from a medical assitant referring to a 4-year-old patient of unknown gender. The patient's medical history, historical drugs, concurrent conditions and concomitant medications were not provided      On 05-OCT-2021, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA)(PROQUAD) 0.5 milliliter, lot number T034614, expiration date 10-APR-2022 (route of administration not provided) for prophylaxis (product storage error).  On that same date, the patient experienced a limited adverse event.      The outcome of adverse event as well as its causal relationship with measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live(PROQUAD) were not reported.  The vaccine underwent a temperature excursion between 6 degrees Farhrenheit (°F) and 14°F, with an average of 8.5°F for 18 minutes, and between 6 degrees Farhrenheit (°F) and 14°F, with an average of 11.9°F for 1 hour. No previous temperature excursions reported.
No problems after vaccine given - 12 hours post vaccine awoke with BP high , symptoms of high BP and achy back/neck - Took extra Metoprolol stayed up 1 hour - fell asleep and slept until noon next day - Felt better and was fine until (one week later) 1/20/21  Same symptoms as before (like coming down with the flu) and spiked BP  - took extra BP med, but BP still high.  Noticed my Arm aching where the vaccine was given and now (was not there after injection) red patch over where vaccine was given. (hot to the touch)